BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9879535)

  • 1. Frequent expression of the c-kit proto-oncogene in canine malignant mammary tumor.
    Kubo K; Matsuyama S; Katayama K; Tsutsumi C; Yonezawa K; Shimada T; Kotani T; Sakuma S; Ohashi F; Takamori Y
    J Vet Med Sci; 1998 Dec; 60(12):1335-40. PubMed ID: 9879535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of c-kit proto-oncogene in canine mastocytoma: a kinetic study using real-time polymerase chain reaction.
    Turin L; Acocella F; Stefanello D; Oseliero A; Fondrini D; Brizzola S; Riva F
    J Vet Diagn Invest; 2006 Jul; 18(4):343-9. PubMed ID: 16921872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression patterns of the erbB subfamily mRNA in canine benign and malignant mammary tumors.
    Matsuyama S; Nakamura M; Yonezawa K; Shimada T; Ohashi F; Takamori Y; Kubo K
    J Vet Med Sci; 2001 Sep; 63(9):949-54. PubMed ID: 11642281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of mutations in the c-kit gene of 32 dogs with mastocytoma.
    Riva F; Brizzola S; Stefanello D; Crema S; Turin L
    J Vet Diagn Invest; 2005 Jul; 17(4):385-8. PubMed ID: 16131001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kit.
    London CA; Galli SJ; Yuuki T; Hu ZQ; Helfand SC; Geissler EN
    Exp Hematol; 1999 Apr; 27(4):689-97. PubMed ID: 10210327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression frequency of c-kit isoforms and its prognostic potential in canine mammary tumours.
    Chen YC; Liao JW; Chang SC; Hsu WL
    Vet Comp Oncol; 2020 Sep; 18(3):303-314. PubMed ID: 31652393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression patterns of the slit subfamily mRNA in canine malignant mammary tumors.
    Tanno T; Tanaka Y; Sugiura T; Akiyoshi H; Takenaka S; Kuwamura M; Yamate J; Ohashi F; Kubo K; Tsuyama S
    J Vet Med Sci; 2006 Nov; 68(11):1173-7. PubMed ID: 17146174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the oncogene c-erbB-2 in canine mammary cancers and tumor-derived cell lines.
    Ahern TE; Bird RC; Bird AE; Wolfe LG
    Am J Vet Res; 1996 May; 57(5):693-6. PubMed ID: 8723884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse mammary tumor virus-like nucleotide sequences in canine and feline mammary tumors.
    Hsu WL; Lin HY; Chiou SS; Chang CC; Wang SP; Lin KH; Chulakasian S; Wong ML; Chang SC
    J Clin Microbiol; 2010 Dec; 48(12):4354-62. PubMed ID: 20881168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of hyperamplification of centrosomes in naturally developing tumors of dogs.
    Setoguchi A; Okuda M; Nishida E; Yazawa M; Ishizaka T; Hong SH; Hisasue M; Nishimura R; Sasaki N; Yoshikawa Y; Masuda K; Ohno K; Tsujimoto H
    Am J Vet Res; 2001 Jul; 62(7):1134-41. PubMed ID: 11453492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations of p53 tumor suppressor gene in spontaneous canine mammary tumors.
    Lee CH; Kweon OK
    J Vet Sci; 2002 Dec; 3(4):321-5. PubMed ID: 12819382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amplification of the cyclin A gene in canine and feline mammary tumors.
    Murakami Y; Tateyama S; Rungsipipat A; Uchida K; Yamaguchi R
    J Vet Med Sci; 2000 Jul; 62(7):783-7. PubMed ID: 10945302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Derlin-1 and stanniocalcin-1 are differentially regulated in metastasizing canine mammary adenocarcinomas.
    Klopfleisch R; Gruber AD
    J Comp Pathol; 2009; 141(2-3):113-20. PubMed ID: 19515379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplification of the c-yes oncogene in canine mammary tumors.
    Rungsipipat A; Tateyama S; Yamaguchi R; Uchida K; Murakami Y; Miyoshi N; Hayashi T
    J Vet Med Sci; 1999 Feb; 61(2):185-9. PubMed ID: 10081762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase reverse transcriptase (TERT) expression in canine mammary tissues: a specific marker for malignancy?
    Zavlaris M; Angelopoulou K; Vlemmas I; Papaioannou N
    Anticancer Res; 2009 Jan; 29(1):319-25. PubMed ID: 19331168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-KIT messenger RNA and protein expression and mutations in canine cutaneous mast cell tumors: correlations with post-surgical prognosis.
    Giantin M; Vascellari M; Morello EM; Capello K; Vercelli A; Granato A; Lopparelli RM; Nassuato C; Carminato A; Martano M; Mutinelli F; Dacasto M
    J Vet Diagn Invest; 2012 Jan; 24(1):116-26. PubMed ID: 22362941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression patterns of connexin 26 and connexin 43 mRNA in canine benign and malignant mammary tumours.
    Gotoh H; Harada K; Suzuki K; Hashimoto S; Yamamura H; Sato T; Fukumoto K; Hagiwara H; Ishida T; Yamada K; Asano R; Yano T
    Vet J; 2006 Jul; 172(1):178-80. PubMed ID: 16772144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of c-kit mutations in canine mast cell tumors using fluorescent polyacrylamide gel electrophoresis.
    Jones CL; Grahn RA; Chien MB; Lyons LA; London CA
    J Vet Diagn Invest; 2004 Mar; 16(2):95-100. PubMed ID: 15053358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the PTEN tumor suppressor gene in malignant mammary gland tumors of dogs.
    Kanae Y; Endoh D; Yokota H; Taniyama H; Hayashi M
    Am J Vet Res; 2006 Jan; 67(1):127-33. PubMed ID: 16426222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the juxtamembrane domain of c-KIT are associated with higher grade mast cell tumors in dogs.
    Zemke D; Yamini B; Yuzbasiyan-Gurkan V
    Vet Pathol; 2002 Sep; 39(5):529-35. PubMed ID: 12243462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.